|
Volumn 52, Issue 12, 2014, Pages 1105-1111
|
Peramivir pharmacokinetics in a patient receiving continuous veno-venous hemodiafiltration during the 2009 H1N1 influenza a pandemic
|
Author keywords
Continuous veno venous hemo diafiltration; CVVHDF; Influenza A(H1N1)pdm09; Peramivir; Pharmacokinetics
|
Indexed keywords
LEVOFLOXACIN;
OSELTAMIVIR;
PERAMIVIR;
PIPERACILLIN PLUS TAZOBACTAM;
VANCOMYCIN;
ANTIVIRUS AGENT;
CYCLOPENTANE DERIVATIVE;
GUANIDINE DERIVATIVE;
SIALIDASE;
2009 H1N1 INFLUENZA;
ACUTE KIDNEY FAILURE;
ADULT;
ANTIBIOTIC THERAPY;
ANTIGEN DETECTION;
AREA UNDER THE CURVE;
ARTICLE;
ARTIFICIAL VENTILATION;
BACKACHE;
BACTEREMIA;
BLOOD SAMPLING;
BRONCHOSCOPY;
CASE REPORT;
CONSTANTS AND COEFFICIENTS;
CONTINUOUS HEMODIAFILTRATION;
COUGHING;
DIALYSATE;
DIALYSIS MEMBRANE;
DISEASE DURATION;
DISEASE SEVERITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DOSE INCREASE;
DRUG DOSE REGIMEN;
DRUG HALF LIFE;
DRUG PROTEIN BINDING;
DYSPNEA;
EFFLUENT;
EXTRACORPOREAL OXYGENATION;
FEMALE;
FEVER;
FLOW RATE;
FLU LIKE SYNDROME;
HOSPITAL INFECTION;
HUMAN;
KIDNEY FUNCTION;
LABORATORY TEST;
LENGTH OF STAY;
LUNG LAVAGE;
MAXIMUM PLASMA CONCENTRATION;
OXYGEN SATURATION;
PLASMA HALF LIFE;
PREGNANT WOMAN;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SATURATION COEFFICIENT;
STREPTOCOCCUS PNEUMONIA;
STREPTOCOCCUS PNEUMONIAE;
THROAT CULTURE;
TREATMENT DURATION;
ULTRAFILTRATION;
VIRUS DETECTION;
ANTAGONISTS AND INHIBITORS;
HEMODIAFILTRATION;
INFLUENZA A VIRUS (H1N1);
INFLUENZA, HUMAN;
ADULT;
ANTIVIRAL AGENTS;
CYCLOPENTANES;
FEMALE;
GUANIDINES;
HEMODIAFILTRATION;
HUMANS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA, HUMAN;
NEURAMINIDASE;
|
EID: 84929655882
PISSN: 09461965
EISSN: None
Source Type: Journal
DOI: 10.5414/CP202161 Document Type: Article |
Times cited : (10)
|
References (11)
|